POP Medical given FDA nod on pelvic device

medicine, healthcare
medicine, healthcare

The company has developed a new method for treating pelvic floor prolapse.

POP Medical (formerly Pro Access) has obtained approval from the US Food and Drug Administration (FDA) for marketing of its medical device for treatment of pelvic floor prolapse. 20% of the women in the world suffer from this condition at any given moment, and 30% at some time in their lives. The condition causes internal organs to exert pressure on the pelvic floor, which can lead to repeat urinary tract infections, vaginal bleeding, pain, discomfort in sexual relations, etc. The accepted treatment was formerly a hysterectomy. In recent years, solutions involving anchoring through an alternative artificial pelvic floor have been developed, but these do not last, and feature bleeding and other side effects.

The newest methods for treating the problem are based on anchoring the existing pelvic floor tissue to the tendons above it. POP Medical's products is a new method of anchoring the pelvic floor to tendons that significantly shortens the duration of treatment (15 minutes, compared with an hour or more in the current methods), reduces pain, and simplifies the treatment, thereby substantially reducing the risk incurred.

The doctor fits the device on his finger like a thimble, inserts his finger into the vagina, identifies the precise location for treatment, and moves tissue liable to be damaged during the process away from the location. Only when the device is in the correct place does the doctor release the harpoon-shaped tacks, which become attached to the tendons. When the doctor removes the device and his finger, he leaves behind surgical stitching thread that completes the anchoring process.

The product was tested on 15 women in a clinical trial in Israel. In every case, a solution for pelvic floor prolapse was achieved, with no side effects recorded.

POP Medical was founded by medical director Prof. Menahem Neuman, and has raised only a few million dollars since it was founded. The company is managed by CEO Debbie Garner, who served in various marketing positions in drug company Eli Lilly, and as a health consultant for Avelere Healthcare, a heath consultant firm that, among other things, focuses on obtaining reimbursement from insurance companies. POP was founded in the Rad Biomed incubator, and received a follow-up investment from the Triventures fund.

Published by Globes [online], Israel business news - www.globes-online.com - on August 7, 2016

© Copyright of Globes Publisher Itonut (1983) Ltd. 2016

medicine, healthcare
medicine, healthcare
Caesarstone kitchen credit: Caesarstone Caesarstone bucks Nasdaq as tariffs boost potential

The Israeli quartz countertop manufacturer company has fallen on hard times due to Chinese rivalry but tariffs could boost its revenue.

ZIM ship credit: ZIM Trump's tariffs torpedo ZIM's share price

ZIM's share price fell 16.4% on Wall Street on Thursday and a further 7.2% on Friday, closing with a market cap of $1.5 billion, wiping out all its gains in 2025.

Israeli apartments Credit: Shutterstock Apartments sold and rented

A selection of recent real estate deals in Israel in Tel Aviv, Holon, Rehovot, Kiryat Tivon, Shlomi and Beersheva.

THAAD anti missile system credit: The US Army Ralph Scott Wikimedia US deploys more THAAD, Patriot batteries in Israel - report

Amid rising regional tensions the US is bolstering Israel's air defense, Saudi state-owned TV channel Al Arabiya reports.

Tel Aviv Stock Exchange credit: Shutterstock TASE tumbles in Wall Street's wake

Dual-listed stocks have again been hard hit, but the banks are also down sharply.

Donald Trump and Benjamin Netanyahu credit: Avi Ohayon Netanyahu due in Washington to discuss tariffs

According to news website Axios, Prime Minister Benjamin Netanyahu will be the first leader to meet President Trump after the latter's announcement of sweeping import tariffs.

Yoni Assia CEO eToro Credit: PR eToro defers IPO amid market turmoil

The online trading platform had planned to begin meetings with investors this week.

Minister of Finance Bezalel Smotrich credit: Shlomi Yosef Smotrich meets wrong man in Washington

Minister of Finance Bezalel Smotrich tried to persuade Secretary of the Treasury Scott Bessent to soften the tariff blow on Israel - only Bessent isn't responsible for the matter.

Unframe founders credit: Yossi Yarom Israeli AI enterprise platform co Unframe raises $50m

Unframe’s turnkey AI solutions enable companies to solve any enterprise AI use case at scale with fully functional, customized AI solutions for businesses in a matter of hours, rather than months.

Combatica credit: Combatica Combatica launches next-gen VR AI training platform

The Israeli company's virtual reality platform includes 50 AI generated scenarios, seven maps and even situations for operating night vision.

Shekel credit: Shutterstock Vladirina 32 Shekel volatility after US tariffs announcement

The shekel is weakening sharply against the euro, which is gaining following the unveiling of Donald Trump's tariffs plan.

Minister of Finance Bezalel Smotrich credit: Noam Moskovitz Knesset Spokesperson Treasury assesses potential damage to Israel's US exports

Israel will be charged a higher tariff on its exports to the US - its biggest export customer - than Turkey and the UAE.

Iranian flag credit: Shutterstock Why inflation haunts Iran

With a month-on-month increase of 3.3% and an annual rate of 37.1%, inflation reflects the struggles of millions of Iranians.

APM merges with lawyers from Doron, Tikotzky Kantor, Gutman credit: Eyal Merilos APM merges with 12 lawyers from Doron, Tikotzky Kantor, Gutman

With the addition of these 12 lawyers, Amit Pollak Matalon & Co. will now have 135 lawyers.

US President Donald Trump credit: Reuters Sipa USA Israel on list as Trump unveils tariffs

Relatively low reciprocal tariffs will be imposed on Israeli goods sold in the US.

Deflated unicorn credit: Shutterstock Big Tech 50 reports more huge falls in startup valuations

Israeli R&D partnership Big Tech 50 reports that an investment of $2 million in Orcam made in 2021, shrank to just $31,000 at the end of 2024.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018